Skip to content
Search

Latest Stories

3 Indian-origin men imprisoned for illegally supplying prescription-only medicines

Three Indian-origin men were sentenced on Monday (7) at Southwark Crown Court for their part in illegally supplying potentially dangerous prescription-only drugs.

Jagdiep Dhonsi, Amrin Mirza and Shirina Ali were arrested following an investigation by the Medicines and Healthcare products Regulatory Agency (MHRA) that resulted in the seizure of more than 300,000 tablets, worth in excess of £315,000.


Dhonsi was sentenced to 38 months imprisonment, Mirza to 18 months imprisonment, and Ali to 9 months imprisonment for their roles in the crimes. They were convicted of conspiracy to supply unauthorised medicines, including diazepam, zolpidem and zopiclone along with other powerful prescription-only medicines.

Alastair Jeffrey, MHRA Head of Enforcement said medicines purchased outside the regulated supply chain cannot be guaranteed to meet standards of quality, safety and effectiveness and can present a real risk to public health.

"Some may contain dangerous ingredients which can have devastating consequences for patients who use them," said Jeffrey. "We work to identify those involved in illegal activities with medicines and will use our powers to investigate fully, confiscate assets and, where necessary, prosecute those putting profit before public health.

"Criminals selling medicines illegally have a flagrant disregard for your health, and only care about making money. Contact a GP or a healthcare professional if you have any concerns about your health."

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Honeywell

Honeywell prepares for a new era under CEO Vimal Kapur

iStock

Why Honeywell's CEO is dismantling the company he spent 37 years building

  • Vimal Kapur is overseeing the biggest shake-up in Honeywell's 141-year history.
  • The industrial giant is splitting into three businesses amid growing investor pressure.
  • Honeywell is betting a leaner structure will drive its next phase of growth.

After spending nearly four decades climbing the ranks at Honeywell, chief executive Vimal Kapur is leading the biggest overhaul in the company's 141-year history. The move may seem counterintuitive, but it reflects changing investor expectations, a shifting industrial landscape and a belief that Honeywell's future may depend on becoming smaller rather than bigger.

Most chief executives brought in to break up companies are outsiders. Vimal Kapur is the opposite.

Keep ReadingShow less